T-LARGE GRANULOCYTIC LEUKEMIA

Clinical trials for T-LARGE GRANULOCYTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new T-LARGE GRANULOCYTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for T-LARGE GRANULOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug combo tested in High-Stakes fight against rare blood cancers

Disease control Completed

This study tested whether adding the drug romidepsin to a stem cell transplant could better control several aggressive types of T-cell blood cancers. Researchers gave romidepsin before and after the transplant to 23 patients to find the safest dose and see if it helped. The main …

Matched conditions: T-LARGE GRANULOCYTIC LEUKEMIA

Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

T-LARGE GRANULOCYTIC LEUKEMIA

Get alerted when new T-LARGE GRANULOCYTIC LEUKEMIA trials appear

New drug combo tested in High-Stakes fight against rare blood cancers